Does recombinant human growth hormone reduce liver fat content in young adults with obesity and NAFLD?
Recombinant human growth hormone may reduce liver fat content in young adults with obesity and NAFLD, though larger studies are needed to confirm this effect.
Data from this pilot study suggest that rhGH treatment in young adults with obesity and NAFLD may have benefits to reduce liver fat content, although larger studies are needed to confirm this effect.
Pan et al. (Sat,) studied this question.